Jill Marie Broadfoot - Nov 20, 2021 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Stock symbol
ACRX
Transactions as of
Nov 20, 2021
Transactions value $
$0
Form type
4
Date filed
11/23/2021, 04:37 PM
Previous filing
Aug 20, 2021
Next filing
Jan 18, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Award $0 +15K $0.00 15K Nov 20, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRX Stock Option (Right to Receive) Award $0 +30K $0.00 30K Nov 20, 2021 Common Stock 30K $0.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units shall vest in three equal consecutive annual installments on November 20, 2022, November 20, 2023 and November 20, 2024.
F3 The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months.